Role of Glial Cells in Retinal Ganglion Cell Death
Principal Investigator
Theresa Good, PhD
Texas A&M University Health Science Center
College Station, TX, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
G1999009
Summary
One hypothesis for how intraocular pressure leads to vision loss is that the cell damage is the result of increased mechanical forces. Dr. Good has proposed that glial cells within the retina contribute to optic nerve damage by producing toxic molecules (nitric oxide and glutamate). She is testing this hypothesis with an in vitro model of shear stress and strain, where retinal glial cells are deformed to mimic the stress that occurs in living eyes and then measuring the production of toxic compounds. Through these measurements, she hopes to identify factors that contribute to retinal ganglion cell death. The ultimate goal of this research is to develop new therapeutic approaches to treating glaucoma.
Related Grants
National Glaucoma Research
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
Mitochondria in Retinal Ganglion Cells
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Rob Nickells, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
Role of a Key Gene, Angptl7, in Steroid-Induced Glaucoma
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dan Stamer, PhD
Current Organization
Duke University School of Medicine
National Glaucoma Research
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California
Enhancing Access to Glaucoma Care Using Artificial Intelligence
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Benjamin Xu, MD, PhD
Current Organization
University of Southern California